Skip to content

Paliperidone

Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion (paliperidone) is a small molecule pharmaceutical. Paliperidone was first approved as Invega on 2006-12-19. It is used to treat bipolar disorder, depressive disorder, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. It has been approved in Europe to treat psychotic disorders and schizophrenia.
Trade Name Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion
Common Name Paliperidone
Indication bipolar disorder, depressive disorder, psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders
Drug Class Antipsychotics (risperidone type)
Paliperidone
Get full access now